Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Finished Goods: 2009-2024

Historic Finished Goods for Fresenius Medical Care AG (FMS) over the last 16 years, with FY2024 value amounting to $1.3 billion.

  • Fresenius Medical Care AG's Finished Goods fell 476.49% to $1.3 billion in Q4 2024 from the same period last year, while for Dec 2024 it was $1.3 billion, marking a year-over-year decrease of 476.49%. This contributed to the annual value of $1.3 billion for FY2024, which is 354.01% down from last year.
  • As of FY2024, Fresenius Medical Care AG's Finished Goods stood at $1.3 billion, which was down 354.01% from $1.3 billion recorded in FY2023.
  • Over the past 5 years, Fresenius Medical Care AG's Finished Goods peaked at $1.4 billion during FY2021, and registered a low of $1.2 billion during FY2020.
  • Over the past 5 years, Fresenius Medical Care AG's median Finished Goods value was $1.3 billion (recorded in 2023), while the average stood at $1.3 billion.
  • Per our database at Business Quant, Fresenius Medical Care AG's Finished Goods soared by 1798.51% in 2020 and then plummeted by 401.07% in 2023.
  • Annual analysis of 5 years shows Fresenius Medical Care AG's Finished Goods stood at $1.2 billion in 2020, then rose by 13.53% to $1.4 billion in 2021, then decreased by 2.06% to $1.4 billion in 2022, then decreased by 4.01% to $1.3 billion in 2023, then dropped by 3.54% to $1.3 billion in 2024.
  • Its Finished Goods stands at $1.3 billion for FY2024, versus $1.3 billion for FY2023 and $1.4 billion for FY2022.